Penning Traps Could Deliver the Sharpest CPT Test Yet via Molecular Hydrogen Ions
Preprint proposes 10^-17 fractional accuracy CPT test using H2+ and anti-H2- vibrational spectroscopy in Penning traps; analysis flags production and systematic challenges while noting synergy with existing g-factor and magnetic-moment measurements.
A recent arXiv preprint (v1, 15 May 2026) by Juan M. Cornejo and colleagues analyzes a route to 10^-17-level comparisons of vibrational frequencies between H2+ and its antimatter counterpart anti-H2- inside Penning traps. This is a theoretical proposal, not an experimental result, with no sample size or empirical data; it relies on detailed modeling of trap dynamics, laser interactions, and readout schemes rather than measured outcomes. The work extends Myers' 2018 suggestion of non-destructive laser spectroscopy by incorporating either the continuous Stern-Gerlach effect or quantum-logic spectroscopy for state detection. While the authors rightly highlight that most required technology already exists in labs such as BASE and ALPHA, they understate the production bottleneck for anti-H2- ions, which has never been demonstrated at the densities needed for repeated measurements. Complementary CPT probes already running in the same infrastructure—electron/positron g-factor comparisons via electron spin resonance and proton/antiproton magnetic-moment tests via radiofrequency drives—could be performed in parallel, creating a multi-channel consistency check that single antihydrogen experiments lack. Key limitations include assumed trap stability at the 10^-18 level and negligible blackbody shifts that will require cryogenic upgrades beyond current BASE setups. Real-world precedents from the 2022 BASE proton g-factor result (Nature 601, 53) and 2023 ALPHA antihydrogen spectroscopy (Nature 621, 516) show that systematic uncertainties often exceed initial projections by an order of magnitude once data taking begins.
HELIX: Realizing anti-H2- at usable rates inside a cryogenic Penning trap would immediately enable a three-way CPT cross-check that current antihydrogen-only programs cannot match.
Sources (3)
- [1]Primary Source(https://arxiv.org/abs/2605.16585)
- [2]Related Source(https://doi.org/10.1038/s41586-021-04203-w)
- [3]Related Source(https://doi.org/10.1038/s41586-022-05529-9)